DanCann Pharma A/S publishes Q3-2021 report
COPENHAGEN, Denmark, 26 November 2021 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma"), a Danish company powered by cannabinoids, hereby today releases its results for the period 1 July – 30 September 2021 (the “period”). The Q3-2021 report is available as an attached document to this press release and on www.dancann.com.Key figures Q2 2021 KDKK 01/07/21 01/07/20 30/09/20 01/01/21 30/09/21 01/01/20 30/09/20 30/09/21Net sales 0 0 0 0Operating -3,429 -1,650 -9,791